您使用提示模式 关闭

SURI - Simplify Propel Opportunities ETF (USD) (US82889N6242)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

全选 清除所有
 
(%)
US82889N6242
SURI ISIN
交易所交易基金 (ETF)
基金类型
Simplify Asset Management
提供商
-
每股资产净值
2023-02-07
成立日期
4 每年的次数
股息的支付
CEOJLS
CFI
SURI
代码
Formed
Status
Equity
投资项目
Healthcare
部门
Global
地区分布
No benchmark
基准
2.54 %
总成本比率
Physical
复制方法
77,01 百万 USD
基金资产总量 | 2026-07-17
77,01 百万 USD
股票类资产 | 2026-07-17
否
UCITS

收益率 在 2026-07-17, NYSE Arca

  • YTD
    8,97 %
  • 1M
    1,21 %
  • 3M
    10,28 %
  • 6M
    13,52 %
  • 1Y
    42,77 %
  • 3Y
    20,88 %
  • 5Y
    -
  • 10Y
    -
按交换价格计算，包括收入支付

最新数据在
添加比较项目
从
至
ADD-IN
Cbonds 加载项 API
债券数据 API

报价 (SURI)

探索最全面的数据库

1 000 000

债券

100 000

股票

175 910

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件
请求访问

价格动态的变化

Fund profile

The Simplify Propel Opportunities ETF is an actively managed ETF that seeks long-term capital appreciation by investing in a portfolio comprised primarily of global biotech, pharma, health care technology, and life science companies

SURI profile

The Simplify Propel Opportunities ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Global. The Simplify Asset Management fund’s base currency is USD and the share class was registered 07.02.2023 with unique ISIN - US82889N6242. Main exchange is NYSE Arca and ticker symbol is SURI. The total expense ratio is 2.54%. The Simplify Propel Opportunities ETF (USD) pays dividends 4 time(s) per year.

结构 SURI 在 2026-07-17

下载结构至 Excel 文档
证券 值
PLAINS GP HLDGS L P 42,32%
ACHIEVE LIFE SCIENCES INC USD 0.001 11,66%
MILESTONE PHARMACEUTICALS INC NPV 5,15%
DELCATH SYS INC USD 0.01 4,34%
ACHIEVE LIFE SCIENCES I WTS 30JUN30 4,11%
PHATHOM PHARMACEUTICALS USD 0.0001 3,54%
CORCEPT THERAPEUTICS INC USD 0.001 3,11%
ABEONA THERAPEUTICS INC USD 0.01 2,51%
CELLDEX THERAPEUTICS INC USD 0.001 2,44%
Cash 2,01%
INVENTIVA SA NPV ADR 1,88%
COMPASS PATHWAYS PLC USD 0.008 ADR 1,83%
KYVERNA THERAPEUTICS IN USD 0.00001 1,77%
AQUESTIVE THERAPEUTICS IN USD 0.001 1,49%
LEONABIO INC USD 0.0001 1,4%
ARTIVA BIOTHERAPEUTICS I USD 0.0001 1,28%
Telesat, 5.625% 6dec2026, USD 1,17%
ZEVRA THERAPEUTICS INC USD 0.0001 1,12%
PALISADE BIO INC USD 0.01 1,11%
ORCHESTRA BIOMED HLDGS I USD 0.0001 1,05%
OCULAR THERAPEUTIX INC USD 0.0001 0,94%
ACHIEVE LIFE SCIENCES WTS 0,89%
EYEPOINT INC 0,67%
IMMUNIC INC USD 0.0001 0,6%
UPSTREAM BIO INC USD 0.001 0,57%
AKERO THERAPEUTICS INC CVR 0,55%
SAB BIOTHERAPEUTICS INC USD 0.0001 0,48%
Chinook Therapeutics, ord. 0%
EIGER BIOPHARMACEUTICALS USD 0.0001 0%
WTS - MILESTONE PHARMACEUTICALS INC SERIES B 0%
JASPER THERAPEUTIC WTS 0%
WTS - TENAYA THERAPEUTICS INC 0%
WTS - QUOIN PHARMACEUTICALS LTD - Series K 0%
ALTIMMUNE INC 0%
WTS - QUOIN PHARMACEUTICALS LTD - Series H 0%
WTS - QUOIN PHARMACEUTICALS LTD - Series J 0%
WTS - QUOIN PHARMACEUTICALS LTD - Series I 0%
显示所有 隐藏
Other - %

其他 ETF 和基金提供商

相关 ETF 和基金

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    资产净值
    {{ item.expense_ratio }}
    总成本比率
你必须 注册 才能获得访问权